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RESULTS
formed consent to the procedure. The cervices of. all
patients were effaced and less than 2 cm dilated and the
membranes were intact. Intra-uterine pressure was re-
corded by a transabdominal intra·amniotic catheter in-
serted after the possibility of an anteriorly situated placenta
had been excluded clinically. Maternal and fetal heart
rates were recorded by a phonocardiograph.
Oxytocin was administered intravenously at a rate suffi-
cient to produce uterine contractions compatible with early
established labour, that is contractions causing a rise of
intra-uterine pressure of about 50 mmHg above resting
pressure every 2 - 3 minutes, with a uterine activity of at
least 150 Alexandria units: The oxytocin was stopped at
this point. When uterine activity had returned to the
original level the procedure was repeated with prostaglan-
din F,a.
At the conclusion of the experiment the membranes were
ruptured and labour was allowed to continue. All patients
were delivered vaginally and all babies were in good
physical condition.
The respective doses of oxytocin and prostaglandin re-
quired to produce a similar degree of uterine activity in
each patient are shown in Table I. It can be seen from
the mean doses of the drugs that the ratio of prostaglandin
to oxytocin is 3.14 : I when potency is compared. There
were no maternal side-effects.
However, the cardiotocograph tracing (Fig. 1) shows that
an abnormal fetal heart rate pattern was obtained with
REFERENCES
I. Donald, I. (1969): Practical Obslelric Problems, 4th ed.. p. 425.
London: Lloyd-Luke.
17 April 1974
All babies were examined neurologically before leaving
hospital, but none demonstrated any overt defects. How-
ever, only after long-term follow-up can the ultimate
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Equivalent doses of oxytocin and prostaglandin F2a re-
quired to produce a specific amount of uterine activity
in vivo in 6 patients at term, were determined. The ratio
of prostaglandin to oxytocin is 3,14 : 1 when potency is
compared. For any further studies designed to compare
these two drugs to have validity, this ratio must be borne
in mind.
For over 10 years oxytocin has been used successfully for
the induction of labour. It has now been established that
theprostaglandins may also be used for this purpose.'" It
is fruitless to argue about which is the stronger of the two
drugs. The clinician wants safe delivery, and equivalent
doses must, therefore, be those which provide this. This
goal must be a prerequisite for any model designed to test
dosage in a clinical comparison.
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Fig. 1. Cardiotocograph tracings showing the effect of prostaglandin F,a (left) and oxytocin (right) on the fetal heart
rate in the same subject.
TABLE I. DRUG DOSAGES AND UTERINE ACTIVITY IN
6 SUBJECTS
Oxytocin Prostaglandin F2lY
Uterine Dose Uterine Dose
Case activity" (mU/min) activity" (,.,.g/min)
1 200 4 224 24
2 227 4 251 8
3 251 8 230 16
4 196 4 184 16
5 234 4 220 16
6 250 4 260 8
Mean 226 4 2/3 228 14 2/3
• Alexand ria units.-4
prostaglandin. This pattern disappeared on discontinuation
of the prostaglandin, but was repeated on substitution of
oxytocin in the same patient.
DISCUSSION
Numerous articles have been published comparing the
efficacy of prostaglandin and oxytocin in labour induc-
tion;'· but no conclusion could be drawn about the relative
effectiveness of the two drugs, as comparable doses of
oxytocin and prostaglandin had not been used. Dewhurst'
feels this to be a major criticism of such studies.
Our finding of a 3,14 : I ratio of the potency of pro-
staglandin compared with oxytocin, should be taken into
account in future comparative trials of tne two drugs.
Although the two substances have different molecular
weights, our finding gives a clinical approximation, and
any investigation designed to compare the efficacy and
the maternal and fetal side-effects of different drugs,
requires such a study.
In our trial an in vivo situation was used which closely
approximated the actual conditions at term when the
drugs would be used. In order to avoid variation between
patients both drugs were given to each subject.
Errors may result from the attempt to relate to clinical
work the findings derived either from in vitro human
studies or from animal studies, whether in vitro or in vivo."
The importance of selecting a good model for comparing
two drugs is brought out in Fig. I. The fact that the
abnormal pattern was obtained with both the drugs in the
same patient illustrates that the placental reserve is critical
in determining the fetal response, and not necessarily the
drug. The finding that fetal distress was produced by
both drugs stresses the importance of having control within
the same patient over the effects of powerful drugs.
We wish to thank Upjohn (Pty) Ltd for the supply of
prostaglandin.
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